Leishmaniasis-HIV coinfection: current challenges

被引:88
作者
Lauletta Lindoso, Jose Angelo [1 ,2 ]
Cunha, Mirella Alves [3 ]
Queiroz, Igor Thiago [4 ]
Valente Moreira, Carlos Henrique [2 ]
机构
[1] Univ Sao Paulo, Lab Soroepidemiol LIM HC FMUSP, Sao Paulo, Brazil
[2] Inst Infectol Emilio Ribas SES, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Med, Dept Infect Dis, Sao Paulo, Brazil
[4] Hosp Giselda Trigueiro SESAP, Natal, RN, Brazil
来源
HIV AIDS-RESEARCH AND PALLIATIVE CARE | 2016年 / 8卷
关键词
leishmaniasis; HIV infection; coinfection; epidemiology; clinical manifestations; diagnosis; treatment;
D O I
10.2147/HIV.S93789
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Leishmaniasis - human immunodeficiency virus (HIV) coinfection can manifest itself as tegumentary or visceral leishmaniasis. Almost 35 countries have reported autochthonous coinfections. Visceral leishmaniasis is more frequently described. However, usual and unusual manifestations of tegumentary leishmaniasis have been reported mainly in the Americas, but the real prevalence of Leishmania infection in HIV-infected patients is not clear. Regarding the clinical manifestations, there are some reports showing unusual manifestations in visceral leishmaniasis and tegumentary leishmaniasis in HIV-infected patients; yet, the usual manifestations are more frequent. Leishmaniasis diagnosis relies on clinical methods, but serological tests are used to diagnose visceral leishmaniasis despite them having a low sensitivity to tegumentary leishmaniasis. The search for the parasite is used to diagnose both visceral leishmaniasis and tegumentary leishmaniasis. Nevertheless, in HIV-infected patients, the sensitivity of serology is very low. Drugs available to treat leishmaniasis are more restricted and cause severe side effects. Furthermore, in HIV-infected patients, these side effects are more prominent and relapses and lethality are more recurrent. In this article, we discuss the current challenges of tegumentary leishmaniasis and visceral leishmaniasis-HIV infection, focusing mainly on the clinical manifestations, diagnosis, and treatment of leishmaniasis.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 91 条
  • [61] Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India
    Mahajan, Raman
    Das, Pradeep
    Isaakidis, Petros
    Sunyoto, Temmy
    Sagili, Karuna D.
    Angeles Lima, Maria
    Mitra, Gaurab
    Kumar, Deepak
    Pandey, Krishna
    Van Geertruyden, Jean-Pierre
    Boelaert, Marleen
    Burza, Sakib
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) : 1255 - 1262
  • [62] American cutaneous leishmaniasis associated with HIV infection: report of four cases
    Mattos, M
    Caiza, A
    Fernandes, O
    Goncalves, AJS
    Pirmez, C
    Souza, CSF
    Oliveira-Neto, MP
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 1998, 10 (03) : 218 - 225
  • [63] HIV and the transmission of Leishmania
    Molina, R
    Gradoni, L
    Alvar, J
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2003, 97 : 29 - 45
  • [64] Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region
    Monge-Maillo, Begona
    Norman, Francesca F.
    Cruz, Israel
    Alvar, Jorge
    Lopez-Velez, Rogelio
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (08):
  • [65] Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS
    Narita, M
    Ashkin, D
    Hollender, ES
    Pitchenik, AE
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (01) : 157 - 161
  • [66] DIAGNOSIS OF SYMPTOMATIC VISCERAL LEISHMANIASIS BY USE OF THE POLYMERASE CHAIN-REACTION ON PATIENT BLOOD
    NUZUM, E
    WHITE, F
    THAKUR, C
    DIETZE, R
    WAGES, J
    GROGL, M
    BERMAN, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) : 751 - 754
  • [67] Organization WH, 2010, WHO TECHNICAL REPORT, pxii
  • [68] Pan American Health Organization WHO, 2013, LEISHM EP REP AM
  • [69] Leishmaniasis at the end of the millennium
    Richard D. Pearson
    Susan M. Lareau
    Selma M. B. Jeronimo
    [J]. Current Infectious Disease Reports, 1999, 1 (5) : 448 - 452
  • [70] Pearson RD, 1999, CURR INFECT DIS REP, V1